PV
Palvella Therapeutics, Inc. (PVLA)
NASDAQ·Healthcare·Biotechnology
$150.33
-0.04%
Mkt Cap $2.26B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (33 analysts)
$232.00
Range $210.00 – $270.00
Implied Upside
+54.3%
Consensus $232.00 vs current $150.33